{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T12:20:29Z","timestamp":1789129229523,"version":"build-2803163510"},"reference-count":69,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007819","name":"Allergan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01GM128183-01A1"],"award-info":[{"award-number":["R01GM128183-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 MH086828"],"award-info":[{"award-number":["R01 MH086828"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01MH095905-01A1"],"award-info":[{"award-number":["R01MH095905-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-MH107615"],"award-info":[{"award-number":["R01-MH107615"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009670","name":"National Alliance for Research on Schizophrenia and Depression","doi-asserted-by":"publisher","award":["25623"],"award-info":[{"award-number":["25623"]}],"id":[{"id":"10.13039\/100009670","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["101BX003631"],"award-info":[{"award-number":["101BX003631"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["101BX004062"],"award-info":[{"award-number":["101BX004062"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000874","name":"NARSAD","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000874","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006636","name":"University of Maryland, Baltimore County","doi-asserted-by":"publisher","award":["15\/300,984"],"award-info":[{"award-number":["15\/300,984"]}],"id":[{"id":"10.13039\/100006636","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["biologicalpsychiatryjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.biopsych.2021.11.024","type":"journal-article","created":{"date-parts":[[2021,12,15]],"date-time":"2021-12-15T17:33:16Z","timestamp":1639589596000},"page":"216-226","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Negative Allosteric Modulation of Gamma-Aminobutyric Acid A Receptors at \u03b15 Subunit\u2013Containing Benzodiazepine Sites Reverses Stress-Induced Anhedonia and Weakened Synaptic Function in Mice"],"prefix":"10.1016","volume":"92","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2110-3274","authenticated-orcid":false,"given":"Timothy A.","family":"Troppoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panos","family":"Zanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Polymnia","family":"Georgiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1511-7183","authenticated-orcid":false,"given":"Todd D.","family":"Gould","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Rudolph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9844-9049","authenticated-orcid":false,"given":"Scott M.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2021.11.024_bib1","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/13811118.2015.1025119","article-title":"The association between anhedonia, suicidal ideation, and suicide attempts in a large student sample","volume":"20","author":"Winer","year":"2016","journal-title":"Arch Suicide Res"},{"key":"10.1016\/j.biopsych.2021.11.024_bib2","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3390\/medicina55080458","article-title":"Can anhedonia be considered a suicide risk factor? A review of the literature","volume":"55","author":"Bonanni","year":"2019","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.biopsych.2021.11.024_bib3","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1177\/070674371405900303","article-title":"Suicidal behaviour in mood disorders\u2014Who, when, and why?","volume":"59","author":"Isomets\u00e4","year":"2014","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.biopsych.2021.11.024_bib4","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1176\/ps.2009.60.11.1439","article-title":"What did STAR\u2217D teach us? Results from a large-scale, practical, clinical trial for patients with depression","volume":"60","author":"Gaynes","year":"2009","journal-title":"Psychiatr Serv"},{"key":"10.1016\/j.biopsych.2021.11.024_bib5","doi-asserted-by":"crossref","first-page":"409","DOI":"10.31887\/DCNS.2008.10.4\/kkelly","article-title":"Toward achieving optimal response: Understanding and managing antidepressant side effects","volume":"10","author":"Kelly","year":"2008","journal-title":"Dialogues Clin Neurosci"},{"key":"10.1016\/j.biopsych.2021.11.024_bib6","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2021.11.024_bib7","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A\u00a0randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2021.11.024_bib8","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1152\/jn.00072.2012","article-title":"NMDAR antagonist action in thalamus imposes \u03b4 oscillations on the hippocampus","volume":"107","author":"Zhang","year":"2012","journal-title":"J\u00a0Neurophysiol"},{"key":"10.1016\/j.biopsych.2021.11.024_bib9","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1093\/schbul\/sbv051","article-title":"Ketamine dysregulates the amplitude and connectivity of high-frequency oscillations in cortical\u2013subcortical networks in humans: Evidence from resting-state magnetoencephalography-recordings","volume":"41","author":"Rivolta","year":"2015","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.biopsych.2021.11.024_bib10","doi-asserted-by":"crossref","first-page":"E3007","DOI":"10.1073\/pnas.1718883115","article-title":"Disinhibition of CA1 pyramidal cells by low-dose ketamine and other antagonists with rapid antidepressant efficacy","volume":"115","author":"Widman","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2021.11.024_bib11","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/s41467-019-13809-8","article-title":"Ketamine disinhibits dendrites and enhances calcium signals in prefrontal dendritic spines [published correction appears in Nat Commun 2021; 12:370]","volume":"11","author":"Ali","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.biopsych.2021.11.024_bib12","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.biopsych.2010.12.015","article-title":"Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure","volume":"69","author":"Li","year":"2011","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2021.11.024_bib13","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.tins.2015.03.003","article-title":"An excitatory synapse hypothesis of depression","volume":"38","author":"Thompson","year":"2015","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.biopsych.2021.11.024_bib14","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nm.4050","article-title":"Synaptic plasticity and depression: New insights from stress and rapid-acting antidepressants","volume":"22","author":"Duman","year":"2016","journal-title":"Nat Med"},{"key":"10.1016\/j.biopsych.2021.11.024_bib15","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1146\/annurev-pharmtox-010617-052811","article-title":"Molecular pharmacology and neurobiology of rapid-acting antidepressants","volume":"59","author":"Gould","year":"2019","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.biopsych.2021.11.024_bib16","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/s41593-021-00868-8","article-title":"Sustained effects of rapidly acting antidepressants require BDNF-dependent MeCP2 phosphorylation","volume":"24","author":"Kim","year":"2021","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.biopsych.2021.11.024_bib17","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1113\/jphysiol.2004.071191","article-title":"\u03b15 subunit-containing GABAA receptors affect the dynamic range of mouse hippocampal kainate-induced gamma frequency oscillations in\u00a0vitro","volume":"559","author":"Towers","year":"2004","journal-title":"J\u00a0Physiol"},{"key":"10.1016\/j.biopsych.2021.11.024_bib18","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1152\/jn.01122.2005","article-title":"Hippocampal network hyperactivity after selective reduction of tonic inhibition in GABAA receptor \u03b15 subunit\u2013deficient mice","volume":"95","author":"Glykys","year":"2006","journal-title":"J\u00a0Neurophysiol"},{"key":"10.1016\/j.biopsych.2021.11.024_bib19","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1152\/jn.01199.2005","article-title":"Specific subtypes of GABAA receptors mediate phasic and tonic forms of inhibition in hippocampal pyramidal neurons","volume":"96","author":"Prenosil","year":"2006","journal-title":"J\u00a0Neurophysiol"},{"key":"10.1016\/j.biopsych.2021.11.024_bib20","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.58731","article-title":"Alterations of specific cortical GABAergic circuits underlie abnormal network activity in a mouse model of Down syndrome","volume":"9","author":"Zorrilla de San Martin","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.biopsych.2021.11.024_bib21","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/cne.903590111","article-title":"GABAA-receptor heterogeneity in the adult rat brain: Differential regional and cellular distribution of seven major subunits","volume":"359","author":"Fritschy","year":"1995","journal-title":"J\u00a0Comp Neurol"},{"key":"10.1016\/j.biopsych.2021.11.024_bib22","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0014-5793(90)80118-3","article-title":"Functional expression and sites of gene transcription of a novel \u03b1 subunit of the GABAA receptor in rat brain","volume":"260","author":"Malherbe","year":"1990","journal-title":"FEBS Lett"},{"key":"10.1016\/j.biopsych.2021.11.024_bib23","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0169-328X(00)00133-9","article-title":"Expression of GABA(A) receptor \u03b15 subunit-like immunoreactivity in human hippocampus","volume":"80","author":"Wainwright","year":"2000","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.biopsych.2021.11.024_bib24","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1038\/npp.2015.112","article-title":"Rapid antidepressant action and restoration of excitatory synaptic strength after chronic stress by negative modulators of alpha5-containing GABAA receptors","volume":"40","author":"Fischell","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2021.11.024_bib25","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.pbb.2018.10.005","article-title":"Comparison of rapid and long-lasting antidepressant effects of negative modulators of \u03b15-containing GABAA receptors and (R)-ketamine in a chronic social defeat stress model","volume":"175","author":"Xiong","year":"2018","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.biopsych.2021.11.024_bib26","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/ijnp\/pyx003","article-title":"Selective pharmacological augmentation of hippocampal activity produces a sustained antidepressant-like response without abuse-related or psychotomimetic effects","volume":"20","author":"Carreno","year":"2017","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.biopsych.2021.11.024_bib27","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0285-16.2017","article-title":"A\u00a0negative allosteric modulator for \u03b15 subunit-containing GABA receptors exerts a rapid and persistent antidepressant-like action without the side effects of the NMDA receptor antagonist ketamine in mice","volume":"4","author":"Zanos","year":"2017","journal-title":"eNeuro"},{"key":"10.1016\/j.biopsych.2021.11.024_bib28","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/s00213-018-4832-9","article-title":"Negative allosteric modulation of alpha 5-containing GABA A receptors engenders antidepressant-like effects and selectively prevents age-associated hyperactivity in tau-depositing mice","volume":"235","author":"Xu","year":"2018","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.biopsych.2021.11.024_bib29","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1038\/s41386-020-0772-2","article-title":"Mechanisms associated with the antidepressant-like effects of L-655,708","volume":"45","author":"Bugay","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2021.11.024_bib30","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.1021\/acs.jmedchem.9b01312","article-title":"Subtype selective \u03b3-aminobutyric acid type A receptor (GABAAR) modulators acting at the benzodiazepine binding site: An update","volume":"63","author":"Maramai","year":"2020","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.biopsych.2021.11.024_bib31","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1124\/jpet.109.157636","article-title":"In\u00a0vitro and in\u00a0vivo properties of 3-tert-butyl-7-(5-methylisoxazol-3-yl)-2-(1-methyl-1H-1,2,4-triazol-5-ylmethoxy)-pyrazolo[1,5-d]-[1,2,4]triazine (MRK-016), a GABAA receptor \u03b15 subtype-selective inverse agonist","volume":"331","author":"Atack","year":"2009","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.biopsych.2021.11.024_bib32","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1124\/pr.117.014449","article-title":"International Union of Basic and Clinical Pharmacology. CVI: GABAA receptor subtype- and function-selective ligands: Key issues in translation to humans","volume":"70","author":"Sieghart","year":"2018","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.biopsych.2021.11.024_bib33","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.neuropharm.2006.04.018","article-title":"L-655,708 enhances cognition in rats but is not proconvulsant at a dose selective for alpha5-containing GABAA receptors","volume":"51","author":"Atack","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopsych.2021.11.024_bib34","doi-asserted-by":"crossref","first-page":"9707","DOI":"10.1523\/JNEUROSCI.0315-15.2015","article-title":"Etomidate impairs long-term potentiation in\u00a0vitro by targeting \u03b15-subunit containing GABAA receptors on nonpyramidal cells","volume":"35","author":"Rodgers","year":"2015","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2021.11.024_bib35","author":"Sandoz"},{"key":"10.1016\/j.biopsych.2021.11.024_bib36","doi-asserted-by":"crossref","first-page":"15669","DOI":"10.1523\/JNEUROSCI.2588-13.2013","article-title":"Chronic stress induces a selective decrease in AMPA receptor-mediated synaptic excitation at hippocampal temporoammonic-CA1 synapses","volume":"33","author":"Kallarackal","year":"2013","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2021.11.024_bib37","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/294763a0","article-title":"Agonist and antagonist benzodiazepine receptor interaction in\u00a0vitro","volume":"294","author":"M\u00f6hler","year":"1981","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2021.11.024_bib38","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/ALN.0000000000001134","article-title":"Effects of \u03b3-aminobutyric acid type A receptor modulation by flumazenil on emergence from general anesthesia","volume":"125","author":"Safavynia","year":"2016","journal-title":"Anesthesiology"},{"key":"10.1016\/j.biopsych.2021.11.024_bib39","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1038\/s41386-020-0663-6","article-title":"Ketamine metabolites, clinical response, and gamma power in a randomized, placebo-controlled, crossover trial for treatment-resistant major depression [published correction appears in Neuropsychopharmacology 2020; 45:1405]","volume":"45","author":"Farmer","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2021.11.024_bib40","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s40263-018-0492-x","article-title":"Convergent mechanisms underlying rapid antidepressant action","volume":"32","author":"Zanos","year":"2018","journal-title":"CNS Drugs"},{"key":"10.1016\/j.biopsych.2021.11.024_bib41","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1037\/0021-843X.92.2.119","article-title":"Social-environmental factors in unipolar depression: Comparisons of depressed patients and nondepressed controls","volume":"92","author":"Billings","year":"1983","journal-title":"J\u00a0Abnorm Psychol"},{"key":"10.1016\/j.biopsych.2021.11.024_bib42","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.1073\/pnas.93.9.3908","article-title":"Hippocampal atrophy in recurrent major depression","volume":"93","author":"Sheline","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2021.11.024_bib43","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/nm.4246","article-title":"Resting-state connectivity biomarkers define neurophysiological subtypes of depression [published correction appears in Nat Med 2017; 23:264]","volume":"23","author":"Drysdale","year":"2017","journal-title":"Nat Med"},{"key":"10.1016\/j.biopsych.2021.11.024_bib44","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1111\/cns.12835","article-title":"Brain structure alterations in depression: Psychoradiological evidence","volume":"24","author":"Zhang","year":"2018","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.biopsych.2021.11.024_bib45","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0306-4522(95)00256-I","article-title":"Stress-induced atrophy of apical dendrites of hippocampal CA3c neurons: Comparison of stressors","volume":"69","author":"Magari\u00f1os","year":"1995","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopsych.2021.11.024_bib46","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0006-8993(03)03042-7","article-title":"Decreased dendritic spine density on prefrontal cortical and hippocampal pyramidal neurons in postweaning social isolation rats","volume":"983","author":"Silva-G\u00f3mez","year":"2003","journal-title":"Brain Res"},{"key":"10.1016\/j.biopsych.2021.11.024_bib47","doi-asserted-by":"crossref","DOI":"10.1126\/science.aat8078","article-title":"Sustained rescue of prefrontal circuit dysfunction by antidepressant-induced spine formation","volume":"364","author":"Moda-Sava","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.biopsych.2021.11.024_bib48","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.neuron.2011.12.033","article-title":"Repeated stress causes cognitive impairment by suppressing glutamate receptor expression and function in prefrontal cortex","volume":"73","author":"Yuen","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.biopsych.2021.11.024_bib49","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.biopsych.2006.02.013","article-title":"A\u00a0neurotrophic model for stress-related mood disorders","volume":"59","author":"Duman","year":"2006","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2021.11.024_bib50","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3389\/fphar.2016.00446","article-title":"Sex-dependent anti-stress effect of an \u03b15 subunit containing GABAA receptor positive allosteric modulator","volume":"7","author":"Piantadosi","year":"2016","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.biopsych.2021.11.024_bib51","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1176\/appi.ajp.2012.12020248","article-title":"Brain-derived neurotrophic factor signaling and subgenual anterior cingulate cortex dysfunction in major depressive disorder","volume":"169","author":"Tripp","year":"2012","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2021.11.024_bib52","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1017\/S1461145710001616","article-title":"GABA-related transcripts in the dorsolateral prefrontal cortex in mood disorders","volume":"14","author":"Sibille","year":"2011","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.biopsych.2021.11.024_bib53","article-title":"Characterization of GABAergic marker expression in the chronic unpredictable stress model of depression","volume":"1","author":"Banasr","year":"2017","journal-title":"Chronic Stress (Thousand Oaks)"},{"key":"10.1016\/j.biopsych.2021.11.024_bib54","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/nature01616","article-title":"Turning on and off recurrent balanced cortical activity","volume":"423","author":"Shu","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2021.11.024_bib55","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1038\/s41467-018-06004-8","article-title":"Dendrite-targeting interneurons control synaptic NMDA-receptor activation via nonlinear \u03b15-GABA A receptors","volume":"9","author":"Schulz","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.biopsych.2021.11.024_bib56","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1093\/cercor\/bhm160","article-title":"Synaptic \u03b15 subunit\u2013containing GABAA receptors mediate IPSPs elicited by dendrite-preferring cells in rat neocortex","volume":"18","author":"Ali","year":"2008","journal-title":"Cereb Cortex"},{"key":"10.1016\/j.biopsych.2021.11.024_bib57","doi-asserted-by":"crossref","first-page":"1127a","DOI":"10.1126\/science.235.4793.1127a","article-title":"Seizures in drug-treated animals","volume":"235","author":"Miczek","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.biopsych.2021.11.024_bib58","doi-asserted-by":"crossref","first-page":"7700","DOI":"10.1038\/s41598-021-87307-7","article-title":"Basmisanil, a highly selective GABAA-\u03b15 negative allosteric modulator: Preclinical pharmacology and demonstration of functional target engagement in man","volume":"11","author":"Hipp","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.biopsych.2021.11.024_bib59","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.bja.2020.11.032","article-title":"Inhibition of a tonic inhibitory conductance in mouse hippocampal neurones by negative allosteric modulators of \u03b15 subunit-containing \u03b3-aminobutyric acid type A receptors: Implications for treating cognitive deficits","volume":"126","author":"Manzo","year":"2021","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.biopsych.2021.11.024_bib60","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.neuron.2020.09.037","article-title":"Relocation of an extrasynaptic GABAA receptor to inhibitory synapses freezes excitatory synaptic strength and preserves memory","volume":"109","author":"Davenport","year":"2021","journal-title":"Neuron"},{"key":"10.1016\/j.biopsych.2021.11.024_bib61","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1523\/JNEUROSCI.0567-18.2018","article-title":"Input-specific synaptic location and function of the \u03b15 GABAA receptor subunit in the mouse CA1 hippocampal neurons","volume":"39","author":"Magnin","year":"2019","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2021.11.024_bib62","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0006-3223(00)00971-9","article-title":"The possibility of neurotoxicity in the hippocampus in major depression: A primer on neuron death","volume":"48","author":"Sapolsky","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2021.11.024_bib63","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/s41586-018-0740-8","article-title":"Reward behaviour is regulated by the strength of hippocampus-nucleus accumbens synapses","volume":"564","author":"LeGates","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2021.11.024_bib64","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1111\/bph.14903","article-title":"Long-lasting correction of in\u00a0vivo LTP and cognitive deficits of mice modelling Down syndrome with an \u03b15-selective GABAA inverse agonist","volume":"177","author":"Duchon","year":"2020","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.biopsych.2021.11.024_bib65","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature17998","article-title":"NMDAR inhibition-independent antidepressant actions of ketamine metabolites","volume":"533","author":"Zanos","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2021.11.024_bib66","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1038\/s41380-018-0028-2","article-title":"Ketamine has distinct electrophysiological and behavioral effects in depressed and healthy subjects","volume":"24","author":"Nugent","year":"2019","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2021.11.024_bib67","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1177\/0269881111405366","article-title":"Specific targeting of the GABA-A receptor \u03b15 subtype by a selective inverse agonist restores cognitive deficits in Down syndrome mice","volume":"25","author":"Braudeau","year":"2011","journal-title":"J\u00a0Psychopharmacol"},{"key":"10.1016\/j.biopsych.2021.11.024_bib68","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/ALN.0000000000002956","article-title":"Perioperative neurocognitive disorder: State of the preclinical science","volume":"132","author":"Eckenhoff","year":"2020","journal-title":"Anesthesiology"},{"key":"10.1016\/j.biopsych.2021.11.024_bib69","doi-asserted-by":"crossref","first-page":"5437","DOI":"10.1172\/JCI76669","article-title":"Sustained increase in \u03b15 GABAA receptor function impairs memory after anesthesia","volume":"124","author":"Zurek","year":"2014","journal-title":"J\u00a0Clin Invest"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322321018394?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322321018394?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:07:31Z","timestamp":1762099651000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322321018394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":69,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S0006322321018394"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2021.11.024","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Negative Allosteric Modulation of Gamma-Aminobutyric Acid A Receptors at \u03b15 Subunit\u2013Containing Benzodiazepine Sites Reverses Stress-Induced Anhedonia and Weakened Synaptic Function in Mice","name":"articletitle","label":"Article Title"},{"value":"Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopsych.2021.11.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Society of Biological Psychiatry.","name":"copyright","label":"Copyright"}]}}